476 related articles for article (PubMed ID: 22844002)
41. Test Accuracy of Human Papillomavirus in Urine for Detection of Cervical Intraepithelial Neoplasia.
Rohner E; Rahangdale L; Sanusi B; Knittel AK; Vaughan L; Chesko K; Faherty B; Tulenko SE; Schmitt JW; Romocki LS; Sivaraman V; Nelson JAE; Smith JS
J Clin Microbiol; 2020 Feb; 58(3):. PubMed ID: 31896666
[TBL] [Abstract][Full Text] [Related]
42. Postcolposcopy management strategies for women referred with low-grade squamous intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
Guido R; Schiffman M; Solomon D; Burke L;
Am J Obstet Gynecol; 2003 Jun; 188(6):1401-5. PubMed ID: 12824969
[TBL] [Abstract][Full Text] [Related]
43. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results.
Manos MM; Kinney WK; Hurley LB; Sherman ME; Shieh-Ngai J; Kurman RJ; Ransley JE; Fetterman BJ; Hartinger JS; McIntosh KM; Pawlick GF; Hiatt RA
JAMA; 1999 May; 281(17):1605-10. PubMed ID: 10235153
[TBL] [Abstract][Full Text] [Related]
44. Cervical cancer screening by high risk HPV testing in routine practice: results at one year recall of high risk HPV-positive and cytology-negative women.
Del Mistro A; Frayle H; Ferro A; Callegaro S; Del Sole A; Stomeo A; Cirillo E; Fedato C; Pagni S; Barzon L; Zorzi M;
J Med Screen; 2014 Mar; 21(1):30-7. PubMed ID: 24488593
[TBL] [Abstract][Full Text] [Related]
45. BD-ProExC as adjunct molecular marker for improved detection of CIN2+ after HPV primary screening.
Depuydt CE; Makar AP; Ruymbeke MJ; Benoy IH; Vereecken AJ; Bogers JJ
Cancer Epidemiol Biomarkers Prev; 2011 Apr; 20(4):628-37. PubMed ID: 21297040
[TBL] [Abstract][Full Text] [Related]
46. An evaluation of human papillomavirus testing for intermediate- and high-risk types as triage before colposcopy.
Hatch KD; Schneider A; Abdel-Nour MW
Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1150-5; discussion 1155-7. PubMed ID: 7726250
[TBL] [Abstract][Full Text] [Related]
47. Human Papilloma Virus Typing as a Triage Tool for Women with Postcoital Bleeding: A Retrospective Cohort Study.
Akdam A; Van Mil L; Tzur Y; Laskov I; Grisaru D; Schejter E; Michaan N
J Womens Health (Larchmt); 2024 Jun; 33(6):734-740. PubMed ID: 38502831
[No Abstract] [Full Text] [Related]
48. Cervical Precancer and Cancer Risk by Human Papillomavirus Status and Cytologic Interpretation: Implications for Risk-Based Management.
Castle PE; Aslam S; Behrens C
Cancer Epidemiol Biomarkers Prev; 2016 Dec; 25(12):1595-1599. PubMed ID: 27587789
[TBL] [Abstract][Full Text] [Related]
49. A prospective study of human papillomavirus (HPV) testing to resolve uncertainty in colposcopy.
Bowring J; Albrow R; Fisher A; Downey G; Cullimore J; Patnick J; Walker PG; Kitchener HC
Cytopathology; 2013 Oct; 24(5):309-13. PubMed ID: 22925374
[TBL] [Abstract][Full Text] [Related]
50. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
51. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
[TBL] [Abstract][Full Text] [Related]
52. Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months.
Bulk S; Bulkmans NW; Berkhof J; Rozendaal L; Boeke AJ; Verheijen RH; Snijders PJ; Meijer CJ
Int J Cancer; 2007 Jul; 121(2):361-7. PubMed ID: 17354241
[TBL] [Abstract][Full Text] [Related]
53. Liquid-based cytology and human papillomavirus testing: a pooled analysis using the data from 13 population-based cervical cancer screening studies from China.
Pan QJ; Hu SY; Guo HQ; Zhang WH; Zhang X; Chen W; Cao J; Jiang Y; Zhao FH; Qiao YL
Gynecol Oncol; 2014 May; 133(2):172-9. PubMed ID: 24631450
[TBL] [Abstract][Full Text] [Related]
54. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology.
Carozzi F; Cecchini S; Confortini M; Becattini V; Cariaggi MP; Pontenani G; Sani C; Ciatto S
Cancer; 2006 Apr; 108(2):119-23. PubMed ID: 16411180
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening.
Rijkaart DC; Berkhof J; van Kemenade FJ; Coupe VM; Hesselink AT; Rozendaal L; Heideman DA; Verheijen RH; Bulk S; Verweij WM; Snijders PJ; Meijer CJ
Int J Cancer; 2012 Feb; 130(3):602-10. PubMed ID: 21400507
[TBL] [Abstract][Full Text] [Related]
56. High-Risk Types of Human Papilloma Virus DNA Testing in Women with False Negative Cytology.
Edblad-Svensson A; Silfverdal L; Collberg P; Tunón K
Acta Cytol; 2018; 62(5-6):411-417. PubMed ID: 30007979
[TBL] [Abstract][Full Text] [Related]
57. Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance.
Safaeian M; Solomon D; Wacholder S; Schiffman M; Castle P
Obstet Gynecol; 2007 Jun; 109(6):1325-31. PubMed ID: 17540804
[TBL] [Abstract][Full Text] [Related]
58. CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings.
Ratnam S; Jang D; Gilbert L; Alaghehbandan R; Schell M; Needle R; Ecobichon-Morris A; Wang PP; Rahman M; Costescu D; Elit L; Zahariadis G; Chernesky M
Papillomavirus Res; 2020 Dec; 10():100206. PubMed ID: 32828968
[TBL] [Abstract][Full Text] [Related]
59. Primary cervical screening with high risk human papillomavirus testing: observational study.
Rebolj M; Rimmer J; Denton K; Tidy J; Mathews C; Ellis K; Smith J; Evans C; Giles T; Frew V; Tyler X; Sargent A; Parker J; Holbrook M; Hunt K; Tidbury P; Levine T; Smith D; Patnick J; Stubbs R; Moss S; Kitchener H
BMJ; 2019 Feb; 364():l240. PubMed ID: 30728133
[TBL] [Abstract][Full Text] [Related]
60. Immediate histologic correlation in women with atypical squamous cells of undetermined significance cytology and positive high-risk HPV: A retrospective review of 6000 cases in a large academic women's hospital.
Zhang H; Pradhan D; Wang T; Ashman D; Matsko J; Zhao C
Cancer Cytopathol; 2020 Nov; 128(11):852-859. PubMed ID: 32639689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]